New discoveries in cancer related immunosuppression are paving the way for an entirely new immunotherapeutic strategy.

Cancer immunotherapy – the treatment approach that utilizes and enhances the power of the immune system - looks promising. Alternative or complementary approaches are also being investigated to enhance the efficacy of the present generation of cancer immunotherapy. Today at the Immunotherapy Bridge 2018 conference in Naples, Italy, organized under the auspices of Melanoma Foundation and SITC (Society for Immunotherapy of Cancer), Assoc. Prof. Leif Hakansson of CanImGuide Therapeutics AB for the first time publicly presented his entirely new scientific discoveries in cancer related